Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:03 PM UTC
| NCT Number | NCT05636618 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | PHASE1 |
| Target Enrollment | 300 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Perspective Therapeutics |
| Last Updated on CT.gov | October 13, 2026 (2 days ago) |
As of October 15, 2026: Clinical trial NCT05636618 is currently recruiting participants. This phase1 study for neuroendocrine tumors is actively seeking new participants at 20 locations across the United States. The study is sponsored by Perspective Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05636618 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05636618 was last updated 2 days ago (October 13, 2026). HelloStudys verifies this status automatically.